152 related articles for article (PubMed ID: 6868483)
1. [Patterns of the dose-effect dependence of chemical carcinogens].
Katul'skiĭ IuN
Vopr Onkol; 1983; 29(6):93-100. PubMed ID: 6868483
[No Abstract] [Full Text] [Related]
2. [Effect of dose fractionation on the carcinogenicity of chemical substances].
Turusov VS
Eksp Onkol; 1984; 6(3):15-20. PubMed ID: 6389085
[TBL] [Abstract][Full Text] [Related]
3. Chrysene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():247-61. PubMed ID: 6586655
[No Abstract] [Full Text] [Related]
4. Dibenz[a,h]anthracene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():299-308. PubMed ID: 6586661
[No Abstract] [Full Text] [Related]
5. [Mathematical dose-effect models in the study of carcinogenesis].
Parfenov IuD
Vopr Onkol; 1986; 32(1):9-22. PubMed ID: 3511610
[No Abstract] [Full Text] [Related]
6. Benzo[ghi]perylene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():195-204. PubMed ID: 6586651
[No Abstract] [Full Text] [Related]
7. Benzo[e]pyrene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():225-37. PubMed ID: 6586653
[No Abstract] [Full Text] [Related]
8. Pyrene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():431-45. PubMed ID: 6586678
[No Abstract] [Full Text] [Related]
9. [Further comment on the threshold of the harmful action of chemical carcinogens].
Ianysheva NIa; Chernichenko IA
Vopr Onkol; 1983; 29(6):84-8. PubMed ID: 6868481
[No Abstract] [Full Text] [Related]
10. [Various suggestions on the unification of methods for experimental substantiation of maximum permissible concentration of chemical carcinogens].
Litvinov NN; Titova TA
Gig Sanit; 1977 Oct; (10):69-73. PubMed ID: 598727
[No Abstract] [Full Text] [Related]
11. [Study of the tumor-forming properties of the domestic chemical substance sintanol DS-10].
Sinigina NV; Sakharov IuI
Gig Sanit; 1974 Jul; (7):109-10. PubMed ID: 4442754
[No Abstract] [Full Text] [Related]
12. [Arguable aspects of the problem of the threshold value in connection with regulating chemical carcinogens].
Kurliandskiĭ BA
Vopr Onkol; 1983; 29(6):80-4. PubMed ID: 6868480
[No Abstract] [Full Text] [Related]
13. Fluorene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():365-71. PubMed ID: 6586671
[No Abstract] [Full Text] [Related]
14. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Bogen KT; Gold LS
Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
[TBL] [Abstract][Full Text] [Related]
15. Carbazole.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():239-45. PubMed ID: 6586654
[No Abstract] [Full Text] [Related]
16. [The dose-effect relationship in connection with the study of the interaction of chemical carcinogens].
Katul'skiĭ IuN
Vopr Onkol; 1988; 34(3):322-30. PubMed ID: 3358296
[TBL] [Abstract][Full Text] [Related]
17. Fluoranthene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():355-64. PubMed ID: 6586670
[No Abstract] [Full Text] [Related]
18. Perylene.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():411-8. PubMed ID: 6586676
[No Abstract] [Full Text] [Related]
19. 2- and 3-Methylfluoranthenes.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():399-404. PubMed ID: 6586674
[No Abstract] [Full Text] [Related]
20. Mechanisms of species, strain, and dose effects in arylamine carcinogenesis.
Weisburger JH; Fiala ES
Natl Cancer Inst Monogr; 1981 Dec; (58):41-8. PubMed ID: 7200572
[No Abstract] [Full Text] [Related]
[Next] [New Search]